Page last updated: 2024-08-05 11:04:56
pyridoindole
null
ChEBI ID: 48888
Members (11)
Member | Definition | Role |
2-amino-3-methyl-9h-pyrido(2,3-b)indole | | 2-Amino-3-methyl-9H-pyrido[2,3-b]indole |
2-amino-9-ethyl-3-pyrido[2,3-b]indolecarboxylic acid ethyl ester | | 2-amino-9-ethyl-3-pyrido[2,3-b]indolecarboxylic acid ethyl ester |
2-amino-9h-pyrido(2,3-b)indole | | 2-Amino-9H-pyrido[2,3-b]indole |
3-amino-1-methyl-5h-pyrido(4,3-b)indole | | 3-Amino-1-methyl-5H-pyrido[4,3-b]indole |
3-amino-1,4-dimethyl-5h-pyrido(4,3-b)indole | | Trp-P-1 |
alosetron | A pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position. | alosetron |
alpha-carboline | | 9H-Pyrido[2,3-b]indole |
gamma-carboline | | 5H-Pyrido[4,3-b]indole |
intoplicine | | intoplicine |
latrepirdine | | latrepirdine |
tubastatin a | A pyridoindole that is 1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indole which is substituted on the tetrahydropyridine nitrogen by a methyl group and on the indole nitrogen by a p-[N-(hydroxy)aminocarbonyl]benzyl group. It is a histone deacetylase 6 (HDAC6) inhibitor that is selective against all the other isozymes (1000-fold) except HDAC8 (57-fold). | tubastatin A |
Research
Studies (905)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
pre-1990 | 112 (12.38) | 18.7374 |
1990's | 163 (18.01) | 18.2507 |
2000's | 270 (29.83) | 29.6817 |
2010's | 283 (31.27) | 24.3611 |
2020's | 77 (8.51) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
Trials | 49 (4.57%) | 5.53% |
Reviews | 106 (9.88%) | 6.00% |
Case Studies | 3 (0.28%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 915 (85.27%) | 84.16% |